ClinicalTrials.gov
public full text
Public Domain
Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder
This human laboratory study aims to assess the effects of cannabidiol on alcohol consumption and craving in participants with alcohol use disorder. In this double-blind within-subject placebo-controlled crossover trial, participants will be randomized to receive both cannabidiol and placebo with a 2-week washout period separating the two treatment phases.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Alcohol Use Disorder and Cannabidiol#908546
- Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders#226157
- Identifying Multiple Mechanisms of Change in Alcoholism Treatment#850357
- Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers#1213146
- A Study Testing the Effects of Different THC Doses on Psychological and Biological Function#1044401
Record · ID 1243147
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive